1Integrated Program in Neuroscience, McGill University, Montréal, Québec, Canada
2Department of Neurology, McGill University, Montreal General Hospital, Montréal, Québec, Canada
3Center for Advanced Research in Sleep Medicine, Hôpital du Sacré-Coeur de Montréal, Montréal, Québec, Canada
4Department of Psychology, Université de Montréal, Montréal, Québec, Canada
5Department of Neuroscience, Université de Montréal, Montréal, Canada
6Center for Studies in Behavioral Neurobiology, PERFORM Center, Department of Health, Kinesiology and Applied Physiology, Concordia University, Montréal, Québec, Canada
7Institut Universitaire de Gériatrie de Montréal and CRIUGM, CIUSSS du Centre-Sud-de-l’Île-de-Montréal, Montréal, Québec, Canada
8Canadian Sleep and Circadian Network (CSCN).
Address correspondence to: Dr Julie Carrier, PhD, Center for Advanced Research in Sleep Medicine, Hôpital du Sacré-Coeur de Montréal, 5400 Boulevard Gouin Ouest, Montréal, Québec H4J 1C5, Canada. E-mail: [email protected]; Dr Ronald B. Postuma, Department of Neurology, L7-305 Montreal General Hospital, 1650 Cedar Ave, Montreal H3G1A4, Canada. E-mail: [email protected]
Received 7 July, 2019
Revised 29 August, 2019
Accepted 29 August, 2019
This abstract is presented in the World Sleep Congress 2019 in Vancouver.
R.B.P. and J.C. contributed equally.
Funding/support: This research was made possible using the data/biospecimens collected by the Canadian Longitudinal Study on Aging (CLSA). Funding for the Canadian Longitudinal Study on Aging (CLSA) is provided by the Government of Canada through the Canadian Institutes of Health Research (CIHR) under grant reference: LSA 9447 and the Canada Foundation for Innovation. This research has been conducted using the CLSA Baseline Comprehensive Dataset version 4.0, under Application Number 160607.
Financial disclosure/conflicts of interest: S.Z., C.Y., C.T., and N.G. have nothing to disclose. A.D. reports grants from Flamel Ireland, Pfizer, Biron, and Canopy Growth, and personal fees from Biogen, outside the submitted work. T. D-V. has nothing to disclose. R.B.P. reports grants and personal fees from Fonds de la Recherche en Sante, grants from Canadian Institute of Health Research, The Parkinson Society of Canada, Weston-Garfield Foundation, Michael J. Fox Foundation, Webster Foundation, personal fees from Takeda, Roche/Prothena, Teva Neurosciences, Novartis, Canada, Biogen, Boehringer Ingelheim, Theranexus, GE HealthCare, Jazz Pharmaceuticals, Abbvie, Jannsen, Otsuka, PhytoPharmica, Inception Sciences, other from Parkinson Canada, outside the submitted work. J.C. reports grants from Merck, Rana, Philipps/Respironics and Canopy Health, outside the submitted work.
Supplemental digital content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal's Website (www.menopause.org).
